Segueix
Mahla Velayati
Mahla Velayati
Correu electrònic verificat a mums.ac.ir
Títol
Citada per
Citada per
Any
Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective
N Zafari, M Velayati, M Fahim, M Maftouh, G Pourali, M Khazaei, M Nassiri, ...
Life Sciences 305, 120760, 2022
332022
Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for colorectal cancer
N Zafari, P Bathaei, M Velayati, F Khojasteh-Leylakoohi, M Khazaei, ...
Computers in Biology and Medicine 155, 106639, 2023
222023
Metabolic pathways regulating colorectal cancer: A potential therapeutic approach
N Zafari, M Velayati, S Damavandi, G Pourali, MG Mobarhan, M Nassiri, ...
Current Pharmaceutical Design 28 (36), 2995-3009, 2022
132022
Growth-hormone-releasing hormone as a prognostic biomarker and therapeutic target in gastrointestinal cancer
S Mehrabadi, M Velayati, N Zafari, SM Hassanian, MG Mobarhan, ...
Current Cancer Drug Targets 23 (5), 346-353, 2023
102023
Mechanism-based pharmacological management of chemotherapy-induced neuropathic pain from preclinical studies to clinical prospective: platinum-based drugs, Taxanes, and Vinca …
N Zafari, M Velayati, M Maftooh, M Khazaei, M Nassiri, SM Hassanian, ...
Current Pharmaceutical Design 29 (16), 1245-1265, 2023
92023
Pharmacological targeting of epithelial-to-mesenchymal transition in colorectal cancer
N Zafari, M Velayati, M Nassiri, M Khazaei, SM Hassanian, GA Ferns, ...
Current Pharmaceutical Design 28 (28), 2298-2311, 2022
92022
Remodeling of the gut microbiota in colorectal cancer and its association with obesity
N Zafari, M Velayati, S Mehrabadi, S Damavandi, M Khazaei, ...
Current Pharmaceutical Design 29 (4), 256-271, 2023
82023
Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis
H Gholamalizadeh, N Zafari, M Velayati, H Fiuji, M Maftooh, E Ghorbani, ...
Clinical and Experimental Medicine 23 (8), 4369-4383, 2023
62023
Therapeutic potential of targeting transforming growth factor-beta (TGF-β) and programmed death-ligand 1 (PD-L1) in pancreatic cancer
G Pourali, N Zafari, M Velayati, S Mehrabadi, M Maftooh, SM Hassanian, ...
Current Drug Targets 24 (17), 1335-1345, 2023
52023
A large population‐based study on the prevalence of electrocardiographic abnormalities: A result of Mashhad stroke and heart atherosclerotic disorder cohort study
S Saffar Soflaei, M Ebrahimi, HR Rahimi, AA Moodi Ghalibaf, M Jafari, ...
Annals of Noninvasive Electrocardiology 28 (6), e13086, 2023
42023
Biosensors for Detection of Hepatitis B Virus
AH Esfandiari, A Vojdani, M Velayati, H Mahaki, Z Meshkat, ...
Current Medicinal Chemistry, 2024
12024
Natriuretic Peptides in Gastrointestinal Cancer: Biomarkers and Potential Therapeutic Targets.
S Sadeghpour, M Velayati, N Zafari, S Mollazadeh, S Mehrabadi, ...
Current Drug Research Reviews, 2023
12023
Bilateral popliteal artery occlusion in a young woman as a rare complication of systemic sclerosis: A case report
M Jokar, N Zafari, M Velayati, K Hashemzadeh
Rheumatology Research 7 (3), 89-92, 2022
12022
Pulmonary thromboembolism: as the first and only presentation of Covid19 infectious
F Akbari, F Rezaeetalab, N Zafari, M Velayati
Journal of Cardio-Thoracic Medicine 9 (2), 829-832, 2021
12021
Atrial Natriuretic Peptide as a Biomarker and Therapeutic Target in Cancer: A Focus on Colorectal Cancer
S Mehrabadi, M Velayati, N Zafari, S Mollazadeh, A Avan
Current Signal Transduction Therapy 19 (2), 52-60, 2024
2024
Charcot arthropathy and acro-osteolysis in a 5-year-old girl with hereditary sensory and autonomic neuropathy type II: A case report
K Hashemzadeh, N Zafari, M Velayati, M Jokar
Rheumatology Research 9 (1), 57-61, 2024
2024
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–16